The future of open access, as the preferred alternative for publication of research results, was widely discussed at the Workshop on Alternative Open Access Publishing Models, held in October 2015 in Belgium. Learn about the participants’ innovative ideas and the recommendations of the European Commission to strengthen and facilitate this business model. The workshop report considers SciELO the most established among the models analyzed. … Read More →
European Commission debates alternative approaches to open access
The Workshop on Alternative Open Access Publishing Models organized by the European Commission in October 2015 convened experts to discuss the future of open access as preferable publication model of research results, especially those financed by public funds. The meeting’s approach prioritized issues beyond the mere access to publications and resulted in fairer and more transparent alternative models aimed at increasing the dissemination and use of research by academia and other sectors of society. … Read More →
Bibliometric indicators of the European scientific production
Europe brings together many countries leaders in scientific and technological research and has encouraged cooperation programs between institutions, countries and regions to foster competitiveness, impact and relevance in research. A comprehensive study based on bibliometric indices analyzes the scientific output of the region and appraises its contribution to the realization of the European Research Area. … Read More →
Sustainability Science in the global landscape
Before the challenge of the Sustainable Development Goals established by the UN for 2030, scientific research has a key role to support decisions and public policies to reach them. A study by Elsevier and SciDev.Net about sustainability science addresses three main aspects, production, impact, and collaboration in research in this area and its interdisciplinarity. … Read More →
The EU will centralize the registry of clinical trials
In April 2014, the European Union approved legislation regulating the registry of clinical trials. This will allow for transnational cooperation between laboratories and institutions of research. The measure will contribute to the transparency and dependability of the trials, and will also allow research into drugs for the treatment of rare diseases. The first registry of clinical trials was created by the WHO in 2004. Currently, registering clinical trials is mandatory in the majority of the countries. … Read More →
Recent Comments